Tuesday, October 16, 2012
Can Lilly capitalize on Alzheimer's breakthrough?
Can Lilly capitalize on Alzheimer's breakthrough? | 2012-10-15 | Indianapolis Business Journal | IBJ.com: Eli Lilly and Co. has apparently made major medical history by being the first to develop a drug that alters the course of Alzheimer’s disease. But whether Lilly can be the first to make major money from a disease-altering Alzheimer’s drug is still in doubt.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment